Global EMRs were built for Western patients with chronic disease. ARICU was built for the patient on Day 7 of dengue with platelets at 18,000 and the family asking about home discharge for a wedding. We don't treat Indian ICUs as edge cases. We treat them as the default.
Every global health AI product treats Indian patients as deviations from a Western norm. ARICU inverts that. The patient who walks in with dengue plus scrub typhus plus falciparum coinfection on Day 7 — the family asking about a wedding discharge — the tier-2 hospital lab without same-day procalcitonin — that's the patient ARICU was designed for from the start.
ARICU's unmatched-product status doesn't come from a feature checklist. It comes from two architectural decisions that competitors cannot replicate in less than 18 months — and that strengthen the longer you use ARICU.
Every suggestion you accept or override teaches the system. After 6 months, ARICU is calibrated to your patient population, your antibiotic resistance patterns, your common presentations. After 12 months, no competitor can match what it knows about your ICU. Switching costs compound monthly. That's a moat global products will never have — because they don't have your patients.
Dengue trajectory prediction. Scrub typhus + dengue coinfection patterns. Snake envenomation by region. Indian drug-brand mapping. Multilingual nurse interfaces. ABDM-ready. A global competitor takes 18 to 24 months to even start building this — and they don't have a 23-year practicing intensivist credibly leading it. We do.
Not a marketing claim. Five concrete architectural commitments that shape every product decision.
Native logic for diseases Western AI has barely seen. Dengue severity prediction with platelet nadir trajectories. Scrub typhus eschar awareness. Malaria with parasite index trends. Leptospirosis early detection. Snake envenomation protocols by region — Russell's viper vs. krait vs. cobra. And coinfection patterns that aren't just two diseases stapled together — "dengue + scrub" is its own clinical entity with its own complication signature.
Indian doctors think in brand names — Magnex, Meronem, Augmentin, Tazact. ARICU recognizes both brand and generic. It knows when a drug is out of stock in your district and suggests equivalents you can actually source. ABDM/ABHA pre-population. IRDAI claim code prep built into discharge summaries. Protocol variants that follow ICMR, not just Surviving Sepsis verbatim.
Nurse-facing screens in 8 Indian languages: Hindi, Telugu, Tamil, Bengali, Marathi, Gujarati, Kannada, Malayalam. AI summarizes patient state in the language the family chooses. Voice input that handles code-switching — English medical terms embedded in Hindi or Telugu narrative. Family WhatsApp updates in local language. The way Indian medicine is actually practiced, not the way American software assumes it should be.
Joint family decisions are documented as joint decisions. Religious sensitivity flags built in — Jehovah's Witness transfusion preferences, orthodox community autopsy refusals. Discharge against medical advice workflows that protect doctor and patient. Financial reality acknowledged in treatment plans — when a family can't afford 3 days of meropenem, ARICU suggests the best feasible alternative, not the textbook ideal.
Most Indian ICUs aren't Apollo or Medanta. ARICU works when not all tests are 24/7. It reasons with what's available — uses clinical proxies when CRP or procalcitonin can't be done. Mobile-first for doctors who round on phone. Affordable for small ICUs from ₹1,900 a month. It's the senior consultant your hospital can't afford full-time.
ARICU is built by Dr. Atul Rai, a practicing intensivist who runs his own hospital. Every alert threshold, every suggestion logic, every score interpretation has been validated against real Indian patients by a doctor who has seen tens of thousands of them.
ARICU isn't an algorithm trained somewhere far away. It's the clinical reasoning of a peer, implemented at scale — used in his own ICU before anyone else sees a new feature. That's the credibility no global competitor can buy.
ARICU is unmatched on two layers, both of which compound. The AI gets smarter for your hospital, month by month. And Indian clinical intelligence is the default, not a feature. The longer you use ARICU, the further ahead it gets.
No credit card. No pilot framing. Just the only ICU AI built for the way Indian medicine is actually practiced. Plans start at ₹1,900/month for individual doctors.